definiens: shall mean the(gro.ss--,;r:-rg§2 on the ( actual in ~ oice y_~OLL ~ GEN for sa ~ Q.L_produc : tsf ~ .. ) ~E?·SlI, _ _ -quan~~!LJ and --.!rade discoU<1 : i ), Cleturns ) _ _ ~l ro_wan,?~~- ' or C adj ~~tment:~3-~51 ~ poJ:.:1 atlQIj ) and IRuranct?)----cni:!f-~e~ I ~ d ( sziT ~ s.-relafed t ~ e~, all as € ctualIy P!!9 > by ' CQI, I, A<;Ft::V. If, prior to sale ot any Product to a third party, COLLAGEN adds biologically active agents to such Product, the Net sale~ Price of such Product shall be ( fiduCed)~"y _ the ac::t~~~ _ cost)to COLLAGEN for the biologically active agents ad<1en . As used herein, the term biologically active agents does not include lhUfTf"'r::-, _ ~~l-±dQ(f_~1 in~<2r ~ nzjrn~ 1J~ te - procc~:,- _ ) co~ l ... 0SLel { . -COLLAGEN and GEN?TYPE~ agree th ~ t any ( 1.?_q_~_t_iQlJ ~ GOLLAGEtJ _ _ - ) of _ the cost of blologlca lly ---.9Cti ve agents l§ _ _ .:!=D~ actuaL_cos_t _, t ~ s-~idenced R':LJ.ny_Qi ~ l { _ ~ct ~ar :) ' paI_d b : t COL ~ GE to a ( nqn - affiliated th_ird partyjfor COLLAGEN 's actual purchase and acquisition coSt OiSElld biologically active agents . _ _ . Such _ l.~Ur_Clld . '::A":_---.9_nd acquisition cost(does not include payments _ ' ~bY COL ~ AGEN for rese ~ rch and devc 1 o·pment and/or production - I costs incurred or paid by COLLAGEN to GENOTYPES or to a _ ~ th.~L-'J, P -- d -- L : ..... ;, : . _ ' : - - - ---- -- _ - t-~!1 t~ ? _ C!ve_~~t~ < : t dny ~roduct _ i ~~ re~-cha_'2ge_d --~--4 CO~~GEN_)t or ( cd1,lsldera}:lQlJ._@lf lc . LJ _ _ lliiD mQn_~, Net Sale_s Prlpe § llilll rrncl':ld ~ thE ' · ~ail .. mal kr.:t _ ~,,;lu~ of suchCcons_tgeratioQJat thE : ' timE : ' of COI"lAGEN ' : ; rel : eipt th('reof